|
HECTD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.781900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.564370E-01 |
| Normal-vs-Stage2 |
7.959100E-03 |
| Normal-vs-Stage3 |
9.863800E-03 |
| Normal-vs-Stage4 |
8.606200E-02 |
| Stage1-vs-Stage2 |
5.224000E-02 |
| Stage1-vs-Stage3 |
7.447500E-02 |
| Stage1-vs-Stage4 |
4.847200E-01 |
| Stage2-vs-Stage3 |
5.255400E-01 |
| Stage2-vs-Stage4 |
2.920400E-01 |
| Stage3-vs-Stage4 |
5.280600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.977800E-02 |
| Normal-vs-AfricanAmerican |
5.615800E-01 |
| Normal-vs-Asian |
3.306000E-01 |
| Caucasian-vs-AfricanAmerican |
5.710800E-01 |
| Caucasian-vs-Asian |
4.733600E-01 |
| AfricanAmerican-vs-Asian |
9.712200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.890100E-02 |
| Normal-vs-Female |
6.375900E-02 |
| Male-vs-Female |
9.136000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.498000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.785850E-02 |
| Normal-vs-Age(61-80Yrs) |
1.239610E-02 |
| Normal-vs-Age(81-100Yrs) |
2.698100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.395800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.912200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.932060E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.094000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.341430E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.452800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.379900E-02 |
| Classical-VS-Follicular |
3.555400E-03 |
| Classical-VS-Other |
3.097800E-01 |
| Classical-VS-Normal |
3.129000E-01 |
| Tall-VS-Follicular |
8.793400E-01 |
| Tall-VS-Other |
1.969160E-01 |
| Tall-VS-Normal |
1.297900E-02 |
| Follicular-VS-Other |
9.163800E-02 |
| Follicular-VS-Normal |
6.379000E-03 |
| Other-VS-Normal |
5.559600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.940900E-03 |
| Normal-vs-N1 |
4.329000E-01 |
| N0-vs-N1 |
1.149190E-01 |
|
|
